Finance

Lists
Why is 51S up 16.67%?
Dive Deeper
51S:FRA
Cynata Therapeutics Ltd
€ 0.0070
+16.67%
(+0.0010) 1D
10-р сарын 9, 22:00:00 (GMT+2)  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 51S...
Open
€ 0.01
High
€ 0.01
Low
€ 0.01
Mkt. cap
4.09 сая
Avg. vol.
0.00
Volume
0.00
52-wk high
€ 0.24
52-wk low
€ 0.00
No. of employees
0
Open
€ 0.01
High
€ 0.01
Low
€ 0.01
Mkt. cap
4.09 сая
Avg. vol.
0.00
Volume
0.00
52-wk high
€ 0.24
52-wk low
€ 0.00
No. of employees
0
News stories
From web sources and news partners
About Cynata Therapeutics Ltd
CEORoss Alexander Macdonald
Employees0
Founded2003
Headquarters-
Sector-
Websitecynata.com
Previous reportsAll values in AUD
Loading Previous Earnings...
Revenue
Net income
All values in AUD
2025 оны 9-р сар
2025 оны 12-р сар
2026 оны 3-р сар
2026 оны 6-р сар
Revenue
855.81 мян
855.81 мян
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
2.77 сая
2.77 сая
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.69 сая
1.69 сая
-763.69 мян
-763.69 мян
Operating expense
2.22 сая
2.22 сая
2.63 сая
2.63 сая
Total operating expenses
2.22 сая
2.22 сая
2.63 сая
2.63 сая
Operating income
-1.36 сая
-1.36 сая
-2.63 сая
-2.63 сая
Other non operating income
-
-
-
-
EBT including unusual items
-1.33 сая
-1.33 сая
-3.29 сая
-3.29 сая
EBT excluding unusual items
-1.33 сая
-1.33 сая
-2.62 сая
-2.62 сая
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
425.31 мян
425.31 мян
527.43 мян
527.43 мян
Net income
-1.33 сая
-1.33 сая
-3.29 сая
-3.29 сая
Net profit margin
-155.55%
-155.55%
-
-
Earnings per share
-
-
-
-
Interest and investment income
30.33 мян
30.33 мян
9.42 мян
9.42 мян
Interest expense
-
-
-
-
Net interest expenses
30.33 мян
30.33 мян
9.42 мян
9.42 мян
Depreciation and amortization charges
-
-
-
-
EBITDA
-1.30 сая
-1.30 сая
-2.56 сая
-2.56 сая
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google аппс